| Dr Joel R Montbriand, MD, FACP | |
|
1755 48th St Ste 100, Boulder, CO 80301-2712 | |
| (303) 604-5000 | |
| (720) 890-0364 |
| Full Name | Dr Joel R Montbriand |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 1755 48th St Ste 100, Boulder, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417980038 | NPI | - | NPPES |
| 100005928 | Other | CO | RAILROAD MEDICARE |
| MOA1328 | Other | CO | BCBS |
| 01288463 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 28846 (Colorado) | Primary |
| Entity Name | Boulder Valley Gastroenterology Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902832603 PECOS PAC ID: 4688577174 Enrollment ID: O20040130001035 |
News Archive
A new study finds that the three most common treatment options administered in the emergency department for patients who experience refractory status epilepticus are equally safe and effective.
Ambit Biosciences Corporation, a recognized global leader in kinase drug discovery and development, announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
The more gray matter you have in the decision-making, thought-processing part of your brain, the better your ability to evaluate rewards and consequences. That may seem like an obvious conclusion, but a new study conducted at the U.S. Department of Energy's Brookhaven National Laboratory is the first to show this link between structure and function in healthy people - and the impairment of both structure and function in people addicted to cocaine.
A new report launched today by the International Osteoporosis Foundation (IOF) in collaboration with the European Federation of Pharmaceutical Industry Associations (EFPIA) reveals that the burden of fractures in Europe has been vastly underestimated.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel R Montbriand, MD, FACP 382 S Arthur Ave, Louisville, CO 80027-3094 Ph: (303) 604-5000 | Dr Joel R Montbriand, MD, FACP 1755 48th St Ste 100, Boulder, CO 80301-2712 Ph: (303) 604-5000 |
News Archive
A new study finds that the three most common treatment options administered in the emergency department for patients who experience refractory status epilepticus are equally safe and effective.
Ambit Biosciences Corporation, a recognized global leader in kinase drug discovery and development, announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock.
Mersana Therapeutics, a platform-based cancer therapeutics company, announced today positive preclinical pharmacokinetic data for its lead development candidate, XMT-1001, which is currently in a Phase 1 clinical trial in patients with advanced solid tumors. The results were presented in a poster session at the AACR 101st Annual Meeting 2010 in Washington, DC, held April 17-21, 2010.
The more gray matter you have in the decision-making, thought-processing part of your brain, the better your ability to evaluate rewards and consequences. That may seem like an obvious conclusion, but a new study conducted at the U.S. Department of Energy's Brookhaven National Laboratory is the first to show this link between structure and function in healthy people - and the impairment of both structure and function in people addicted to cocaine.
A new report launched today by the International Osteoporosis Foundation (IOF) in collaboration with the European Federation of Pharmaceutical Industry Associations (EFPIA) reveals that the burden of fractures in Europe has been vastly underestimated.
› Verified 8 days ago
Ms. Martha E Montour, RN Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 580 Mohawk Dr, Boulder, CO 80303 Phone: 303-440-2690 | |
Chester J Dreiman, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2562 Briarwood Dr, Boulder, CO 80305 Phone: 303-501-2195 | |
Pamela G Ingram, MSN Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 580 Mohawk Dr, Boulder, CO 80303 Phone: 303-554-5164 | |
Bradley D Fanestil, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4801 Riverbend Rd Ste 120b, Boulder, CO 80301 Phone: 303-415-8615 Fax: 303-293-0628 | |
Dr. Joseph Randall Lutt, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1840 Folsom St Ste 105, Boulder, CO 80302 Phone: 720-494-4706 Fax: 720-494-4706 | |
Dr. Amy O Campbell, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2880 Folsom St Ste 100, Boulder, CO 80304 Phone: 303-327-7047 Fax: 303-443-7168 | |
Wael F. Garas, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5495 Arapahoe Ave Ste 100, Boulder, CO 80303 Phone: 303-415-4250 Fax: 303-440-9629 |